These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 19671483
1. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma. Xie J, Xiong L, Tao X, Li X, Su Y, Hou X, Shi H. Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483 [Abstract] [Full Text] [Related]
2. In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirus. Xie J, Guo X, Liu F, Luo J, Duan F, Tao X. Cell Immunol; 2015 Sep; 297(1):46-52. PubMed ID: 26140980 [Abstract] [Full Text] [Related]
6. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. J Immunol; 1998 Dec 01; 161(11):6238-44. PubMed ID: 9834111 [Abstract] [Full Text] [Related]
8. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein. Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG. Cancer Lett; 2007 Dec 18; 258(2):189-98. PubMed ID: 17931768 [Abstract] [Full Text] [Related]
9. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T. Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096 [Abstract] [Full Text] [Related]
10. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL. J Immunol; 1999 Jul 15; 163(2):699-707. PubMed ID: 10395660 [Abstract] [Full Text] [Related]
11. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Hariu H, Hirohashi Y, Torigoe T, Asanuma H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K, Mano Y, Kitamura H, Kobayashi J, Tsukahara T, Shijubo N, Sato N. Clin Cancer Res; 2005 Feb 01; 11(3):1000-9. PubMed ID: 15709165 [Abstract] [Full Text] [Related]
16. Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model. Kim HS, Kim CH, Park MY, Park JS, Park HM, Sohn HJ, Kim HJ, Kim SG, Oh ST, Kim TG. Immunol Lett; 2010 Jun 15; 131(1):73-80. PubMed ID: 20211203 [Abstract] [Full Text] [Related]
17. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K. J Immunol; 1999 Jan 01; 162(1):144-51. PubMed ID: 9886380 [Abstract] [Full Text] [Related]
18. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W, He L, Cao X. Zhonghua Yi Xue Za Zhi; 1999 Mar 01; 79(3):170-3. PubMed ID: 11601032 [Abstract] [Full Text] [Related]
19. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG, Luo YH, Liang GP, Yang SM. J Pathol; 2009 Apr 01; 217(5):685-92. PubMed ID: 19142972 [Abstract] [Full Text] [Related]
20. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12. Okada N, Iiyama S, Okada Y, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T, Fujita T, Yamamoto A. Cancer Gene Ther; 2005 Jan 01; 12(1):72-83. PubMed ID: 15389286 [Abstract] [Full Text] [Related] Page: [Next] [New Search]